Get startedLog in
    Picture of Oxford Cannabinoid Technologies Holdings logo

    OCTP — Oxford Cannabinoid Technologies Holdings News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Oxford Cannabinoid Says Lead Drug Candidate Poised To Complete Phase I Clinical Trial In Q3 2023

    Picture of Oxford Cannabinoid Technologies Holdings logoOxford Cannabinoid Technologies Holdings
    31/08/2023 07:15
    Aug 31 (Reuters) - Oxford Cannabinoid Technologies
Holdings PLC  OCTP.L :
    * OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC FY DILUTED
LOSS PER
SHARE 0.62 PENCE VERSUS 0.49 PENCE LOSS YEAR AGO
    * OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC - LEAD DRUG
CANDIDATE, OCT461201, IS POISED TO COMPLETE ITS PHASE I CLINICAL
TRIAL IN Q3 2023

Source text for Eikon:  ID:nRSe8684Ka 
Further company coverage:  OCTP.L 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Oxford Cannabinoid Technologies Holdings

    See all news